111 related articles for article (PubMed ID: 12538346)
1. Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia.
Matheson EC; Hall AG
Carcinogenesis; 2003 Jan; 24(1):31-8. PubMed ID: 12538346
[TBL] [Abstract][Full Text] [Related]
2. Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow.
Matheson EC; Hall AG
Adv Exp Med Biol; 1999; 457():579-83. PubMed ID: 10500837
[TBL] [Abstract][Full Text] [Related]
3. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia.
Best A; Matheson E; Minto L; Hall AG; Irving JA
Leuk Res; 2010 Aug; 34(8):1098-102. PubMed ID: 20233627
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
6. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
[TBL] [Abstract][Full Text] [Related]
7. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
8. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
9. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.
Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N
Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.
Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J
Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442
[TBL] [Abstract][Full Text] [Related]
11. Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.
Poley JW; Wagner A; Hoogmans MM; Menko FH; Tops C; Kros JM; Reddingius RE; Meijers-Heijboer H; Kuipers EJ; Dinjens WN;
Cancer; 2007 Jun; 109(11):2349-56. PubMed ID: 17440981
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the mismatch repair system in bladder cancer.
Thykjaer T; Christensen M; Clark AB; Hansen LR; Kunkel TA; Ørntoft TF
Br J Cancer; 2001 Aug; 85(4):568-75. PubMed ID: 11506498
[TBL] [Abstract][Full Text] [Related]
14. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
[TBL] [Abstract][Full Text] [Related]
15. Analysis of yeast MSH2-MSH6 suggests that the initiation of mismatch repair can be separated into discrete steps.
Bowers J; Tran PT; Liskay RM; Alani E
J Mol Biol; 2000 Sep; 302(2):327-38. PubMed ID: 10970737
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer.
Teruya-Feldstein J; Greene J; Cohen L; Popplewell L; Ellis NA; Offit K
Leuk Lymphoma; 2002 Aug; 43(8):1619-26. PubMed ID: 12400605
[TBL] [Abstract][Full Text] [Related]
17. Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukemia.
Maung ZT; Hogarth L; Reid MM; Proctor SJ; Hamilton PJ; Hall AG
Leukemia; 1994 Sep; 8(9):1487-91. PubMed ID: 8090028
[TBL] [Abstract][Full Text] [Related]
18. A novel protein complex distinct from mismatch repair binds thioguanylated DNA.
Krynetski EY; Krynetskaia NF; Gallo AE; Murti KG; Evans WE
Mol Pharmacol; 2001 Feb; 59(2):367-74. PubMed ID: 11160874
[TBL] [Abstract][Full Text] [Related]
19. Assessing how reduced expression levels of the mismatch repair genes MLH1, MSH2, and MSH6 affect repair efficiency.
Kansikas M; Kasela M; Kantelinen J; Nyström M
Hum Mutat; 2014 Sep; 35(9):1123-7. PubMed ID: 24924810
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
